Showing 2611-2620 of 5262 results for "".
- BTL Taps Drew Barrymore as First Emsculpt Celebrity Ambassadorhttps://practicaldermatology.com/news/btl-taps-drew-barrymore-as-first-emscuplt-celebrity-ambassador/2460052/Drew Barrymore is Emsculpt's first celebrity ambassador. Through her partnership with Emsculpt, the actress and lifestyle mogul will share her treatment experience and results with media and on her social media channels. Ba
- Study:Colorescience’s EnviroScreen Technology Fights Sun Damage, Environmental Factorshttps://practicaldermatology.com/news/studycoloresciences-enviroscreen-technology-fights-sun-damage-environmental-factors/2460051/Colorescience’s Patented EnviroScreen Technology suppresses free radical formation and demonstrates superior performance when tested against comparable products, according to a study in The Journal of Co
- Hispanic and Black Children More Likely to Miss School Due to Eczema Than White Childrenhttps://practicaldermatology.com/news/hispanic-and-black-children-more-likely-to-miss-school-due-to-eczema-than-white-children/2460036/Hispanic and black children are more likely than white children to miss school due to chronic eczema, a new study in JAMA Dermatology shows. Researchers from the Perelman School of Medicine at the University of Pennsylva
- National Emsculpt Week Kicks Offhttps://practicaldermatology.com/news/national-emsculpt-week-kicks-off/2460033/BTL has proclaimed the week of May 20 "National Emsculpt Week," in honor of the first and only non-invasive treatment to go beyond the elimination of fat cells to strengthen and define muscles. National Emsculpt Week was just registered with the National Day Calendar organization,
- Pilot Study: ESWT Improves Wound Healing Before Surgeryhttps://practicaldermatology.com/news/pilot-study-eswt-improves-wound-healing-before-surgery/2460032/Extracorporeal shockwaves (ESWT) initiated within the operation field prior to surgery may improve wound healing and minimize scar formation, according to a pilot study in Lasers in Surgery and Medicine (LSM). The
- Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIAhttps://practicaldermatology.com/news/nestle-enters-into-negotiations-to-sell-nestle-skin-health-to-consortium-led-by-eqt-and-adia/2460031/Nestlé has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale of Nestlé Skin Health for a value of CHF 10.2 billion. Nestlé Skin Health
- Abeona Therapeutics to Present EB-101 Data at Society for Investigative Dermatology Annual Meetinghttps://practicaldermatology.com/news/abeona-therapeutics-to-present-eb-101-data-at-society-for-investigative-dermatology-annual-meeting/2460024/Long-term follow up data from a completed Phase 1/2 study evaluating EB-101 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) will be presented at the 77th Annual Meeting of the Society for Investigative Dermatology (SID) in Chicago. The data will be presented by Stanfor
- Sunscreen Chemicals Found in the Bloodstream: Experts React to the New Findingshttps://practicaldermatology.com/news/sunscreen-chemicals-found-in-bloodstream-experts-react-to-the-new-findings/2460023/Several active ingredients found in different sunscreens enter the bloodstream at levels that far exceed the FDA's recommended threshold without a government safety inspection, a new study in Journal of the American M
- Kamedis: Clinical Study Validates Traditional Chinese Botanical for Eczemahttps://practicaldermatology.com/news/kamedis-clinical-study-validates-traditional-chinese-botanical-for-eczema/2460020/Traditional Chinese botanicals in homeopathic over-the-counter Kamedis Calm Eczema Therapy Cream play a pivotal role in the product’s ability to reduce eczema rashes, according to results of a new study announced by the company. Results show that commer
- SkinBioTherapeutics Names New Executive Directorhttps://practicaldermatology.com/news/skinbiotherapeutics-names-new-executive-director/2460012/Stuart Ashman is the new executive director of SkinBioTherapeutics. Mr. Ashman will succeed Professor Cath O’Neill as CEO after a period of transition. Ms. O’Neill will continue to drive the science and the ongoing commercial